BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 8825429)

  • 1. Dialysis membrane biocompatibility: effects on cellular elements.
    Coli L; De Sanctis LB; Feliciangeli G; Iannelli S; Scolari MP; Todeschini P; Tumietto F; Costigliola P; Chiodo F
    Nephrol Dial Transplant; 1995; 10 Suppl 10():27-32. PubMed ID: 8825429
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of haemodialysis on coagulation and platelets: are we measuring membrane biocompatibility?
    Ward RA
    Nephrol Dial Transplant; 1995; 10 Suppl 10():12-17. PubMed ID: 8825427
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adhesion molecules in patients with chronic renal failure treated with haemodialysis].
    Musiał K; Zwolińska D
    Pol Merkur Lekarski; 2002 Sep; 13(75):177-81. PubMed ID: 12474564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meltspun cellulose diacetate and polysulfone membranes have the same effect on complement activation and expression of leukocyte adhesion molecules and complement receptors.
    Dameche L; Brunet P; George F; André-Pinon S; Bernard D; Sampol J; Berland Y
    Nephrol Dial Transplant; 1995; 10 Suppl 10():33-8. PubMed ID: 8825430
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent advances in the biocompatibility of haemodialysis membranes.
    Hakim RM
    Nephrol Dial Transplant; 1995; 10 Suppl 10():7-11. PubMed ID: 8825426
    [No Abstract]   [Full Text] [Related]  

  • 6. Dialysis membrane biocompatibility and mortality and morbidity in acute renal failure.
    Himmelfarb J; Hakim RM
    J Nephrol; 1997; 10(2):63-4. PubMed ID: 9238611
    [No Abstract]   [Full Text] [Related]  

  • 7. Are biocompatible membranes superior for hemodialysis therapy?
    van Ypersele de Strihou C
    Kidney Int Suppl; 1997 Nov; 62():S101-4. PubMed ID: 9350694
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased soluble CD14 levels in patients on hemodialysis. Influence of dialysate endotoxin or incompatibility to dialyzer membranes?
    Mitzner S; Stange J; Pichel K; Handschuk I; Korten G; Ehlers M; Schutt C; Schmidt R
    ASAIO J; 1995; 41(3):M707-8. PubMed ID: 8573897
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of aluminum removal between hemodialysis with polycarbonate low flux membrane and hemofiltration with polysulfone high flux membrane in end-stage renal failure patients.
    Klemm A; Sperschneider H; Winnefeld K; Günther K; Stein G
    Clin Nephrol; 1997 Feb; 47(2):133-4. PubMed ID: 9049466
    [No Abstract]   [Full Text] [Related]  

  • 10. Biocompatible dialysis membranes and acute renal failure: a study in post-operative acute tubular necrosis in cadaveric renal transplant recipients.
    Valeri A; Radhakrishnan J; Ryan R; Powell D
    Clin Nephrol; 1996 Dec; 46(6):402-9. PubMed ID: 8982557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatibility of dialysis membrane.
    Kes P
    Acta Med Croatica; 1999; 53(1):29-40. PubMed ID: 10437275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hemodialysis membranes: a historical perspective, current state and future prospect.
    Cheung AK; Leypoldt JK
    Semin Nephrol; 1997 May; 17(3):196-213. PubMed ID: 9165649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes.
    Krieter DH; Lemke HD; Wanner C
    Nephrol Dial Transplant; 2006 Feb; 21(2):546; author reply 546. PubMed ID: 16249195
    [No Abstract]   [Full Text] [Related]  

  • 14. [Activation of monocytes during hemodialysis].
    Stetsiuk EA; Osmolovskaia SV; Koval'chuk LV; Gankovskaia LV; Iarmolinskiĭ IS
    Ter Arkh; 1988; 60(6):57-60. PubMed ID: 3206372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialysis fluid and water: their roles in biocompatibility.
    Berland Y; Brunet P; Ragon A; Reynier JP
    Nephrol Dial Transplant; 1995; 10 Suppl 10():45-7. PubMed ID: 8825432
    [No Abstract]   [Full Text] [Related]  

  • 16. Biocompatibility and the clinical choice of dialysis membranes.
    Mujais SK; Ivanovich P; Bereza LA; Vidovich M
    Contrib Nephrol; 1995; 113():101-9. PubMed ID: 7712716
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of continuous implantable renal replacement: past and future.
    Fissell WH; Fleischman AJ; Humes HD; Roy S
    Transl Res; 2007 Dec; 150(6):327-36. PubMed ID: 18022594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience with the multiple use of dialyzers].
    Strokov AG; Poz IaL; Baeva LB; Levitskiĭ ER; Annenkov AE; Rud'ko IA; Kubatiev AA
    Ter Arkh; 1994; 66(6):60-5. PubMed ID: 7940372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the type of dialyser on the clinical outcome in chronic haemodialysis patients: does it really matter?
    Grooteman MP; Nubé MJ
    Nephrol Dial Transplant; 2004 Dec; 19(12):2965-70. PubMed ID: 15507481
    [No Abstract]   [Full Text] [Related]  

  • 20. Biocompatibility aspects of chronic hemodialysis and their clinical relevance.
    Wauters JP
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S19-23. PubMed ID: 8608656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.